ZNF410

ZNF410 is a highly conserved pentadactyl zinc-finger transcription factor that acts as a remarkably selective transcriptional activator, with its erythroid chromatin occupancy concentrated essentially at a single locus, CHD4 (PMID:33301730, PMID:33859416). It binds two evolutionarily conserved regulatory elements bearing homotypic clusters of ZNF410 motifs that have no counterparts elsewhere in the genome, and these elements fully account for its downstream effects (PMID:33301730, PMID:33859416). Cooperative binding to these clustered sites controls chromatin accessibility and enhancer activity at the CHD4 locus, with a subset of 3' enhancer motifs acting as accessibility 'switch motifs' and the SWI/SNF complex selectively required to support cooperative ZNF410 occupancy (PMID:40158221). Because CHD4 is a NuRD component, loss of ZNF410 lowers CHD4 protein by ~60% and de-represses the fetal hemoglobin (γ-globin) genes, an effect that operates partially independently of BCL11A (PMID:33859416, PMID:35526095). DNA binding by full-length ZNF410 is autoinhibited: an N-terminal hairpin loop rich in acidic and Ser/Thr residues mimics DNA and occupies the zinc-finger interface in the absence of substrate, and must be displaced for engagement; the protein is monomeric and binds DNA 1:1 (PMID:36660822). In senescent fibroblasts, the same protein (APA-1) is stabilized by SUMO-1 modification and activates extracellular matrix-remodeling genes including MMP1 and PAI2, binding and transactivating the MMP1 promoter (PMID:12370286).

1. 2002 Medium

   Established ZNF410/APA-1 as a bona fide transcriptional activator and identified its first regulatory layer, showing it binds and transactivates a target promoter and is post-translationally stabilized by SUMO-1.

   Evidence Overexpression, promoter binding and transactivation assays, SUMO-1 modification and half-life measurement in senescent human fibroblasts

   PMID:12370286

   Open questions at the time

   • Genome-wide target specificity not assessed
   • SUMO acceptor site not mapped
   • Not independently replicated
2. 2020 High

   Resolved why ZNF410 matters in erythroid cells by showing it directly activates a single gene, CHD4, through unique conserved binding-site clusters, linking it to fetal hemoglobin silencing via NuRD.

   Evidence CRISPR-Cas9 screen, in vitro DNA binding, X-ray crystallography, and xenotransplantation loss-of-function in human erythroid systems

   PMID:33301730

   Open questions at the time

   • Mechanism of single-gene selectivity beyond motif clustering unresolved
   • Did not address chromatin-remodeling cofactors
3. 2021 High

   Independently confirmed the CHD4-restricted occupancy model and quantified the effect, showing ~60% CHD4 reduction is sufficient to de-repress fetal hemoglobin without toxicity.

   Evidence ChIP-seq, ZNF410 and mouse Zfp410 knockout, quantitative HbF flow cytometry, xenotransplantation

   PMID:33859416

   Open questions at the time

   • Does not explain how partial CHD4 loss yields disproportionate de-repression
   • Therapeutic window in patient cells not defined
4. 2022 Medium

   Positioned ZNF410 in the HbF regulatory hierarchy by showing it represses fetal hemoglobin through a pathway partially independent of BCL11A, supporting combinatorial targeting.

   Evidence Dual lentiviral shmiR knockdown of BCL11A and ZNF410, HbF flow cytometry, sickling assay, and Berkeley SCD mouse xenotransplantation

   PMID:35526095

   Open questions at the time

   • Molecular point of convergence/divergence with BCL11A unmapped
   • Additive ~10% effect is modest
5. 2023 Medium

   Explained how full-length ZNF410 controls its own DNA binding, identifying an N-terminal DNA-mimicking hairpin loop that autoinhibits the zinc-finger interface until displaced.

   Evidence SAXS, AlphaFold modeling with biophysical validation, and in vitro DNA-binding affinity assays

   PMID:36660822

   Open questions at the time

   • Autoinhibition model not validated by mutagenesis
   • Physiological trigger for loop displacement unknown
6. 2025 Medium

   Defined the chromatin mechanism of activation, showing cooperative binding to homotypic clustered sites and a selective SWI/SNF requirement set CHD4 enhancer accessibility.

   Evidence ATAC-seq, ChIP-seq, motif deletion/mutagenesis, SWI/SNF perturbation, and reporter assays at the CHD4 locus

   PMID:40158221

   Open questions at the time

   • Direct physical ZNF410-SWI/SNF interaction not demonstrated
   • Single lab, not independently replicated

• How ZNF410 reconciles its erythroid single-gene selectivity with its broader activator role in fibroblast senescence remains unresolved.
• Cell-type determinants of target selectivity unknown
• Whether SUMO regulation and autoinhibition operate at the CHD4 locus untested
• No unified model linking erythroid and senescence functions